Trial Profile

Can Donepezil Preserve Autobiographical Memory Post Electroconvulsive Therapy? A Randomized, Placebo-Controlled Trial

Status: Discontinued

Phase of Trial: Phase II/III

Latest Information Update: 13 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Donepezil (Primary)
Indications Memory disorders
Focus Therapeutic Use
Acronyms PorterAH

Most Recent Events

03 Jul 2018 Status changed from recruiting to discontinued.
05 Apr 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018.
29 Jun 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com